{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:24:04Z","timestamp":1774463044971,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1992,12]]},"DOI":"10.1007\/bf02247727","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T20:57:00Z","timestamp":1132693020000},"page":"477-483","source":"Crossref","is-referenced-by-count":22,"title":["D1\/D2 dopamine and N-methyl-d-aspartate (NMDA) receptor participation in experimental catalepsy in rats"],"prefix":"10.1007","volume":"109","author":[{"given":"Anita","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02247727_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(87)90733-3","volume":"143","author":"J Arnt","year":"1987","unstructured":"Arnt J, Perregaard J (1987) Synergistic interaction between dopamine D1 and D2 receptor agonists: circling behaviour of rats with hemitransection. Eur J Pharmacol 143:45\u201353","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(87)90144-0","volume":"133","author":"J Arnt","year":"1987","unstructured":"Arnt J, Hyttel J, Perregaard J (1987) Dopamine D1 receptor agonists combined with the selective D2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 133:137\u2013145","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4684-5191-7_10","volume-title":"Neurobiology of central D1 dopamine receptors","author":"AR Braun","year":"1986","unstructured":"Braun AR, Barone P, Chase TN (1986) Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviours. In: Breese GR, Greese I (eds) Neurobiology of central D1 dopamine receptors. Plenum Press, New York pp 151\u2013166"},{"key":"BF02247727_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(86)90588-1","volume":"131","author":"AR Braun","year":"1986","unstructured":"Braun AR, Chase TN (1986) Obligatory D1\/D2 receptor interaction in the generation of dopamine agonist related behaviours. Eur J Pharmacol 131:301\u2013306","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01258633","volume":"75","author":"M Carlsson","year":"1989","unstructured":"Carlsson M, Carlsson A (1989a) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221\u2013226","journal-title":"J Neural Transm"},{"key":"BF02247727_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01255820","volume":"77","author":"M Carlsson","year":"1989","unstructured":"Carlsson M, Carlsson A (1989b) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77:65\u201371","journal-title":"J Neural Transm"},{"key":"BF02247727_CR7","first-page":"272","volume":"13","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia \u2014 implications for schizophrenia and Parkinson's disease. TINS 13:272\u2013276","journal-title":"TINS"},{"key":"BF02247727_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ddr.430020204","volume":"2","author":"BV Clineschmidt","year":"1982","unstructured":"Clineschmidt BV, Martin GE, Bunting PR, Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo(a, d) cyclohepten-5, 10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev Res 2:135\u2013145","journal-title":"Drug Dev Res"},{"key":"BF02247727_CR9","first-page":"722","volume":"248","author":"DW Clow","year":"1989","unstructured":"Clow DW, Jhamandas K (1989) Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J Pharmacol Exp Ther 248:722\u2013728","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02247727_CR10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0024-3205(79)90147-4","volume":"24","author":"RG Fessler","year":"1978","unstructured":"Fessler RG, Sturgeon RD, Meltzer HY (1978) Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra. Life Sci 24:1281\u20131288","journal-title":"Life Sci"},{"key":"BF02247727_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(85)90178-5","volume":"116","author":"ED French","year":"1985","unstructured":"French ED, Pilapil C, Quirion R (1985) Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system. Eur J Pharmacol 116:1\u20139","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0014-2999(89)90346-4","volume":"166","author":"M Hiramatsu","year":"1989","unstructured":"Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioural and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166:359\u2013366","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF00207249","volume":"93","author":"S Hjorth","year":"1987","unstructured":"Hjorth S, Carlsson A (1987) Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D1 agonist SK &F 38393. Psychopharmacology 93:534\u2013537","journal-title":"Psychopharmacology"},{"key":"BF02247727_CR14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0024-3205(86)90291-2","volume":"39","author":"WH Hsu","year":"1986","unstructured":"Hsu WH, Schaffer DD, Dyer DC (1986) The emetic effect of B-HT 920 and apomorphine in dogs: antagonism by haloperidol. Life Sci 39:1021\u20131026","journal-title":"Life Sci"},{"key":"BF02247727_CR15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0028-3908(84)90079-0","volume":"23","author":"J Hyttel","year":"1984","unstructured":"Hyttel J (1984) Functional evidence for selective dopamine D1 receptor blockade by SCH 23390. Neuropharmacology 23:1395\u20131401","journal-title":"Neuropharmacology"},{"key":"BF02247727_CR16","first-page":"462","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnett A, Leitz FH, House VP, Korduba CA (1983) SCH-23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462\u2013468","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02247727_CR17","first-page":"12","volume":"9","author":"DC Javitt","year":"1987","unstructured":"Javitt DC (1987) Negative symptomatology and the PCP (phencyclidine) model of schizophrenia. Hill-side J Clin Psychiatry 9:12\u201335","journal-title":"Hill-side J Clin Psychiatry"},{"key":"BF02247727_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1254\/jjp.30.129","volume":"30","author":"SK Ku\u0142karni","year":"1980","unstructured":"Ku\u0142karni SK, Arzi A, Kaul PN (1980) Modification of drug induced catatonia and tremors by quipazine in rats and mice. Jpn J Pharmacol 30:129\u2013135","journal-title":"Jpn J Pharmacol"},{"key":"BF02247727_CR19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0024-3205(89)90370-6","volume":"44","author":"SK Kulkarni","year":"1989","unstructured":"Kulkarni SK, Ticku MK (1989) Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK-801 against MES- and picrotoxin-induced convulsions in rats. Life Sci 44:1317\u20131323","journal-title":"Life Sci"},{"key":"BF02247727_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(91)90381-Y","volume":"195","author":"S Liljequist","year":"1991","unstructured":"Liljequist S, Ossowska K, Grabowska-Anden M, Anden N-E (1991) Effect of the NMDA receptor antagonist, MK-801 on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55\u201361","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0028-3908(86)90027-4","volume":"25","author":"M Mashurano","year":"1986","unstructured":"Mashurano M, Waddington JL (1986) Stereotyped behaviour in response to the selective D2 receptor agonist RU 24213 is enhanced by pretreatment with the selective D1 agonist SKF 38393. Neuropharmacology 25:947\u2013949","journal-title":"Neuropharmacology"},{"key":"BF02247727_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0024-3205(90)90054-U","volume":"46","author":"AK Mehta","year":"1990","unstructured":"Mehta AK, Ticku MK (1990) Role of N-methyl-d-aspartate (NMDA) receptors in experimental catalepsy in rats. Life Sci 46:37\u201342","journal-title":"Life Sci"},{"key":"BF02247727_CR23","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/0024-3205(88)90324-4","volume":"42","author":"E Meller","year":"1988","unstructured":"Meller E, Bordi F, Bohmaker K (1988) Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213. Life Sci 42:2561\u20132567","journal-title":"Life Sci"},{"key":"BF02247727_CR24","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(80)90592-5","volume":"26","author":"PR Mitchell","year":"1980","unstructured":"Mitchell PR, Doggett NS (1980) Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs. Life Sci 26:2073\u20132081","journal-title":"Life Sci"},{"key":"BF02247727_CR25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0014-2999(90)90066-F","volume":"182","author":"M Morelli","year":"1990","unstructured":"Morelli M, Di Chiara G (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182:611\u2013612","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR26","first-page":"84","volume":"137","author":"C Morpurgo","year":"1962","unstructured":"Morpurgo C (1962) Effect of antiparkinsonian drugs on a phenothiazine induced catatonia reaction. Arch Int Pharmacodyn 137:84\u201390","journal-title":"Arch Int Pharmacodyn"},{"key":"BF02247727_CR27","first-page":"176","volume":"11","author":"EB Nielsen","year":"1985","unstructured":"Nielsen EB, Andersen PH (1985) Behavioral evidence that SK&F 38393 is a partial agonist at dopamine receptors. Soc Neurosci Abstr 11:176","journal-title":"Soc Neurosci Abstr"},{"key":"BF02247727_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(88)90504-3","volume":"146","author":"C Pifl","year":"1988","unstructured":"Pifl C, Hornykiewicz O (1988) Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D1 receptor stimulation. Eur J Pharmacol 146:189\u2013191","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1471-4159.1979.tb11096.x","volume":"32","author":"PJ Roberts","year":"1979","unstructured":"Roberts PJ, Anderson SD (1979) Stimulatory effect of L-glutamate and related amino acids on3H-dopamine release from rat striatum: an in vitro model for glutamate actions. J Neurochem 32:1539\u20131545","journal-title":"J Neurochem"},{"key":"BF02247727_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(86)91178-9","volume":"384","author":"GS Robertson","year":"1986","unstructured":"Robertson GS, Robertson HA (1986) Synergistic effects of D1 and D2 dopamine agonists on turning behavior in rats. Brain Res 384:387\u2013390","journal-title":"Brain Res"},{"key":"BF02247727_CR31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(89)90007-5","volume":"32","author":"WJ Schmidt","year":"1989","unstructured":"Schmidt WJ, Bubser M (1989) Anticataleptic effects of the N-methyl-d-aspartate antagonist MK-801 in rats. Pharmacol Biochem Behav 32:621\u2013623","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247727_CR32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/271766a0","volume":"271","author":"R Schwarcz","year":"1978","unstructured":"Schwarcz R, Creese I, Coyle JT, Snyder SH (1978) Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature 271:766\u2013768","journal-title":"Nature"},{"key":"BF02247727_CR33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2999(78)90148-6","volume":"50","author":"PE Setler","year":"1978","unstructured":"Setler PE, Sarau HM, Zircle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419\u2013430","journal-title":"Eur J Pharmacol"},{"key":"BF02247727_CR34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/285355a0","volume":"285","author":"SH Snyder","year":"1980","unstructured":"Snyder SH (1980) Phencyclidine. Nature 285:355\u2013356","journal-title":"Nature"},{"key":"BF02247727_CR35","doi-asserted-by":"crossref","unstructured":"Spencer NJ (1976) Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester:evidence for glutamic acid as an excitatory transmitter in the rat striatum 102:91\u2013101","DOI":"10.1016\/0006-8993(76)90577-1"},{"key":"BF02247727_CR36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/294366a0","volume":"294","author":"JC Stoof","year":"1981","unstructured":"Stoof JC, Kebabian JW (1981) Opposing roles for D1 and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366\u2013368","journal-title":"Nature"},{"key":"BF02247727_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.2042-7158.1991.tb06649.x","volume":"43","author":"A Verma","year":"1991","unstructured":"Verma A, Kulkarni SK (1991a) \u03b12-Adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920. J Pharm Pharmacol 43:131\u2013133","journal-title":"J Pharm Pharmacol"},{"key":"BF02247727_CR38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.2042-7158.1991.tb03501.x","volume":"43","author":"A Verma","year":"1991","unstructured":"Verma A, Kulkarni SK (1991b) Dopamine receptor mediated hypothermic action of B-HT 920 in rats. J Pharm Pharmacol 43:421\u2013424","journal-title":"J Pharm Pharmacol"},{"key":"BF02247727_CR39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.2042-7158.1991.tb03490.x","volume":"43","author":"A Verma","year":"1991","unstructured":"Verma A, Kulkarni SK (1991c) Chronic electroconvulsive shock alters hypothermic response of B-HT 920 and SKF 38393 in rats. J Pharm Pharmacol 43:813\u2013814","journal-title":"J Pharm Pharmacol"},{"key":"BF02247727_CR40","first-page":"123","volume":"29","author":"A Verma","year":"1991","unstructured":"Verma A, Kulkarni SK (1991d) Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice. Ind J Exp Biol 29:123\u2013126","journal-title":"Ind J Exp Biol"},{"key":"BF02247727_CR41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02245171","volume":"107","author":"A Verma","year":"1992","unstructured":"Verma A, Kulkarni SK (1992) Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 107:431\u2013436","journal-title":"Psychopharmacology"},{"key":"BF02247727_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(89)90046-6","volume":"43","author":"JL Waddington","year":"1989","unstructured":"Waddington JL, O'Boyle KM (1989) Drug acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol Ther 43:1\u201352","journal-title":"Pharmacol Ther"},{"key":"BF02247727_CR43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1471-4159.1988.tb13260.x","volume":"50","author":"EHF Wong","year":"1988","unstructured":"Wong EHF, Knight AR, Woodruff GN (1988) [3H] MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274\u2013281","journal-title":"J Neurochem"},{"key":"BF02247727_CR44","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.76.10.5372","volume":"76","author":"SR Zukin","year":"1979","unstructured":"Zukin SR, Zukin RS (1979) Specific [3H]-phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76:5372\u20135376","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02247727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02247727\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02247727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T03:53:07Z","timestamp":1586577187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02247727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["BF02247727"],"URL":"https:\/\/doi.org\/10.1007\/bf02247727","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]}}}